IF 1.8 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Pharmacogenomics & Personalized Medicine Pub Date : 2025-09-10 eCollection Date: 2025-01-01 DOI:10.2147/PGPM.S525556
Hongwei Li, Yongjun He, Zhengyao Cai, Qianqiu Che, Yong Wu, Mingshuang Zhou, Zeng He, Liming Zhao
{"title":"Whole Exome Sequencing Reveals Novel Genetic Variants Associated with Atrial Septal Defect in a Tibetan Patient Cohort.","authors":"Hongwei Li, Yongjun He, Zhengyao Cai, Qianqiu Che, Yong Wu, Mingshuang Zhou, Zeng He, Liming Zhao","doi":"10.2147/PGPM.S525556","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Atrial septal defect (ASD) is a common congenital heart defect with incompletely understood genetic underpinnings, particularly in specific ethnic groups. This study aimed to identify novel genetic variants related to ASD within the Tibetan population using whole exome sequencing (WES).</p><p><strong>Methods: </strong>Genomic DNA was extracted from blood samples of 17 Tibetan ASD patients. WES was performed using the Illumina HiSeq platform. After rigorous filtering, detection, and annotation of single nucleotide variations (SNVs) and insertion-deletions (InDels), potentially pathogenic variants were prioritized. Functional impact predictions were conducted using SIFT, PolyPhen V2, MutationTaster, and CADD databases to identify variants likely contributing to ASD etiology.</p><p><strong>Results: </strong>We identified nine high-confidence candidate variants in Tibetan ASD patients, including rs145116532 (<i>ALKAL1</i>, c.287G >A: p. R96Q), rs374798430 (<i>AVL9</i>, c.1267G >A: p.D423N), rs138933092 (<i>C5</i>, c.4432C >T: p.R1478W), rs141638421 (<i>CRYAB</i>, c.470G>A: p.R157H), rs147287319 (<i>DOCK8</i>, c.989G>A: c.1193G>A: p.R330Q, p.R398Q), rs141616597 (<i>NTN3</i>, c.1243C>T: p.R415C), rs117506395 (<i>PIWIL1</i>, c.2207C>T: p.T736M), rs142533677 (<i>PLEKHG4</i>, c.2246G>A: p.R749Q), and rs118203532 (<i>TSC1</i>, c.1460C>G: p.S487C). Function annotation further suggested potential associations of <i>C5, CRYAB, PIWIL1</i>, and <i>TSC1</i> with congenital heart diseases.</p><p><strong>Conclusion: </strong>This first WES-based study of Tibetan ASD patients reveals population-specific genetic determinants. The nine novel candidate variants, particularly in <i>C5, CRYAB, PIWIL1</i>, and <i>TSC1</i>, provide preliminary insights into ASD etiology in high-altitude populations and highlight potential targets for future diagnostic biomarker development.</p>","PeriodicalId":56015,"journal":{"name":"Pharmacogenomics & Personalized Medicine","volume":"18 ","pages":"239-250"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12433626/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacogenomics & Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/PGPM.S525556","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

目的:房间隔缺损(ASD)是一种常见的先天性心脏缺陷,其遗传基础尚不完全清楚,特别是在特定的种族群体中。WES采用Illumina HiSeq平台进行。经过严格的筛选、检测和注释单核苷酸变异(snv)和插入缺失(InDels),潜在的致病变异被优先考虑。使用SIFT、PolyPhen V2、MutationTaster和CADD数据库进行功能影响预测,以确定可能导致ASD病因的变异。287G >A: p. R96Q), rs374798430 (AVL9, c.1267G >A: p. d423n), rs138933092 (C5, c.4432C >A: p. r1478w), rs141638421 (CRYAB, c.470G>A: p. r157h), rs147287319 (DOCK8, c.989G>A: c.1193G>A: p. r330q, p. r398q), rs141616597 (NTN3, c.1243C>T: p. r415c), rs117506395 (pik1, c.2207C>T: p. r736m), rs142533677 (PLEKHG4, c.2246G>A: p. r749q), rs118203532 (TSC1, c.1460C>G: p. s487c)。功能注释进一步提示C5、CRYAB、PIWIL1和TSC1与先天性心脏病的潜在关联。9个新的候选变异,特别是C5、CRYAB、PIWIL1和TSC1,为高海拔人群的ASD病因学提供了初步的见解,并突出了未来诊断生物标志物开发的潜在靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Whole Exome Sequencing Reveals Novel Genetic Variants Associated with Atrial Septal Defect in a Tibetan Patient Cohort.

Whole Exome Sequencing Reveals Novel Genetic Variants Associated with Atrial Septal Defect in a Tibetan Patient Cohort.

Whole Exome Sequencing Reveals Novel Genetic Variants Associated with Atrial Septal Defect in a Tibetan Patient Cohort.

Objective: Atrial septal defect (ASD) is a common congenital heart defect with incompletely understood genetic underpinnings, particularly in specific ethnic groups. This study aimed to identify novel genetic variants related to ASD within the Tibetan population using whole exome sequencing (WES).

Methods: Genomic DNA was extracted from blood samples of 17 Tibetan ASD patients. WES was performed using the Illumina HiSeq platform. After rigorous filtering, detection, and annotation of single nucleotide variations (SNVs) and insertion-deletions (InDels), potentially pathogenic variants were prioritized. Functional impact predictions were conducted using SIFT, PolyPhen V2, MutationTaster, and CADD databases to identify variants likely contributing to ASD etiology.

Results: We identified nine high-confidence candidate variants in Tibetan ASD patients, including rs145116532 (ALKAL1, c.287G >A: p. R96Q), rs374798430 (AVL9, c.1267G >A: p.D423N), rs138933092 (C5, c.4432C >T: p.R1478W), rs141638421 (CRYAB, c.470G>A: p.R157H), rs147287319 (DOCK8, c.989G>A: c.1193G>A: p.R330Q, p.R398Q), rs141616597 (NTN3, c.1243C>T: p.R415C), rs117506395 (PIWIL1, c.2207C>T: p.T736M), rs142533677 (PLEKHG4, c.2246G>A: p.R749Q), and rs118203532 (TSC1, c.1460C>G: p.S487C). Function annotation further suggested potential associations of C5, CRYAB, PIWIL1, and TSC1 with congenital heart diseases.

Conclusion: This first WES-based study of Tibetan ASD patients reveals population-specific genetic determinants. The nine novel candidate variants, particularly in C5, CRYAB, PIWIL1, and TSC1, provide preliminary insights into ASD etiology in high-altitude populations and highlight potential targets for future diagnostic biomarker development.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pharmacogenomics & Personalized Medicine
Pharmacogenomics & Personalized Medicine Biochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
3.30
自引率
5.30%
发文量
110
审稿时长
16 weeks
期刊介绍: Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability. In particular, emphasis will be given to: Genomic and proteomic profiling Genetics and drug metabolism Targeted drug identification and discovery Optimizing drug selection & dosage based on patient''s genetic profile Drug related morbidity & mortality intervention Advanced disease screening and targeted therapeutic intervention Genetic based vaccine development Patient satisfaction and preference Health economic evaluations Practical and organizational issues in the development and implementation of personalized medicine programs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信